HAE R&D Expenses
Haemonetics Corp · R&D Expenses
HAE R&D Expenses
Latest reported$16.20Mperiod ending
HAE Quarterly R&D Expenses ($0.00 → $16.20M)
Quarterly R&D Expenses
High-resolution chart · PNG
HAE r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 16,200,000 | |
| 14,446,000 | |
| 14,287,000 | |
| 14,523,000 | |
| 16,261,000 | |
| 15,959,000 | |
| 15,829,000 | |
| 14,139,000 | |
| 14,449,000 | |
| 24,457,000 | |
| 13,265,000 | |
| 12,665,000 | |
| 12,648,000 | |
| 24,144,000 | |
| 12,689,000 | |
| 10,896,000 | |
| 10,902,000 | |
| 21,610,000 | |
| 10,037,000 | |
| 10,853,000 | |
| 12,701,000 | |
| 18,643,000 | |
| 7,501,000 | |
| 6,763,000 | |
| 7,750,000 | |
| 17,174,000 | |
| 7,000,000 | |
| 7,422,000 | |
| 7,487,000 | |
| 8,747,000 | |
| 8,978,000 | |
| 8,583,000 | |
| 9,406,000 | |
| 11,087,000 | |
| 12,427,000 | |
| 7,521,000 | |
| 8,193,000 | |
| 19,021,000 | |
| 8,462,000 | |
| 8,336,000 | |
| 11,437,000 | |
| 22,049,000 | |
| 10,942,000 | |
| 11,553,000 | |
| 11,321,000 | |
| 17,225,000 | |
| 10,643,000 | |
| 10,938,000 | |
| 15,382,000 | |
| 13,836,000 | |
| 14,209,000 | |
| 14,946,000 | |
| 11,209,000 | |
| 17,818,000 | |
| 10,588,000 | |
| 10,827,000 | |
| 9,409,000 | |
| 8,611,000 | |
| 9,232,000 | |
| 10,350,000 | |
| 8,609,000 | |
| 8,786,000 | |
| 7,996,000 | |
| 7,954,000 | |
| 7,920,000 | |
| 6,662,000 | |
| 6,461,000 | |
| 6,475,000 | |
| 6,777,000 | |
| 6,958,000 | |
| 5,840,000 | |
| 5,217,000 | |
| 5,844,000 | |
| 5,790,000 | |
| 5,529,000 | |
| 6,727,000 | |
| 6,276,000 | |
| 6,539,000 | |
| 5,804,000 | |
| 6,119,000 | |
| 5,422,000 | |
| 5,229,000 | |
| 9,463,000 | |
| 6,283,000 | |
| 5,541,000 | |
| 5,103,000 | |
| 6,584,000 | |
| 4,253,000 | |
| 4,054,000 | |
| 4,102,000 | |
| 4,072,000 | |
| 4,622,000 | |
| 4,997,000 | |
| 4,830,000 | |
| 4,633,000 | |
| 5,110,000 | |
| 4,939,000 | |
| -5,436,000 | |
| 15,146,000 | |
| 4,988,000 |